Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Article

  • Article
    DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer
    Adam Kashishian, Heather Douangpanya, Darcey Clark, Stephen T. Schlachter, C. Todd Eary, Justin G. Schiro, Hongmei Huang, Larry E. Burgess, Edward A. Kesicki and James Halbrook
    Mol Cancer Ther December 1 2003 2 (12) 1257-1264;

  • Article
    Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
    Curtis D. Hose, Melinda Hollingshead, Edward A. Sausville and Anne Monks
    Mol Cancer Ther December 1 2003 2 (12) 1265-1272;

  • Article
    Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells
    Roberto R. Rosato, Jorge A. Almenara, Yun Dai and Steven Grant
    Mol Cancer Ther December 1 2003 2 (12) 1273-1284;

  • Article
    Nitric oxide does not mediate but inhibits transformation and tumor phenotype
    Arindam Dhar, June M. Brindley, Cristi Stark, Michael L. Citro, Larry K. Keefer and Nancy H. Colburn
    Mol Cancer Ther December 1 2003 2 (12) 1285-1293;

  • Article
    Inhibition of tumor growth by a novel approach: In situ allicin generation using targeted alliinase delivery
    Talia Miron, Marina Mironchik, David Mirelman, Meir Wilchek and Aharon Rabinkov
    Mol Cancer Ther December 1 2003 2 (12) 1295-1301;

  • Article
    Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation
    Stéphane Honore, Kathy Kamath, Diane Braguer, Leslie Wilson, Claudette Briand and Mary Ann Jordan
    Mol Cancer Ther December 1 2003 2 (12) 1303-1311;

  • Article
    E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model
    Zhichao Zhou, Rong-Rong Zhou, Hui Guan, Corazon D. Bucana and Eugenie S. Kleinerman
    Mol Cancer Ther December 1 2003 2 (12) 1313-1319;

  • Article
    Hematopoietic expression of O6-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O6-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea
    Emiko L. Kreklau, Karen E. Pollok, Barbara J. Bailey, Naili Liu, Jennifer R. Hartwell, David A. Williams and Leonard C. Erickson
    Mol Cancer Ther December 1 2003 2 (12) 1321-1329;

  • Article
    Antitumor activity of the novel melphalan containing tripeptide J3 (l-prolyl-l-melphalanyl-p-l-fluorophenylalanine ethyl ester): Comparison with its m-l-sarcolysin analogue P2
    Joachim Gullbo, Charlotta Wallinder, Marcus Tullberg, Henrik Lövborg, Hans Ehrsson, Rolf Lewensohn, Peter Nygren, Kristina Luthman and Rolf Larsson
    Mol Cancer Ther December 1 2003 2 (12) 1331-1339;

  • Article
    Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents
    Yuying Liu, Lawrence H. Cheung, Walter N. Hittelman and Michael G. Rosenblum
    Mol Cancer Ther December 1 2003 2 (12) 1341-1350;

  • Article
    Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon
    Shuichi Taniguchi, Yasushi Mochida, Takeshi Uchiumi, Tomoko Tahira, Kenshi Hayashi, Koichi Takagi, Mitsuo Shimada, Yoshihiko Maehara, Hiroyuki Kuwano, Suminori Kono, Hitoo Nakano, Michihiko Kuwano and Morimasa Wada
    Mol Cancer Ther December 1 2003 2 (12) 1351-1359;

  • Article
    Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
    Ramzi M. Mohammad, Ayad Al-Katib, Amro Aboukameel, Daniel R. Doerge, Fazlul Sarkar and Omer Kucuk
    Mol Cancer Ther December 1 2003 2 (12) 1361-1368;

  • Article
    Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells
    Yoon-Pin Lim, Lang-Shi Diong, Robert Qi, Brian J. Druker and Richard J. Epstein
    Mol Cancer Ther December 1 2003 2 (12) 1369-1377;

Acknowledgment to Reviewers

  • Acknowledgment to Reviewers
    Acknowledgment to Reviewers
    Mol Cancer Ther December 1 2003 2 (12) 1379-1380;

Author Index

  • Author Index
    Author Index
    Mol Cancer Ther December 1 2003 2 (12) 1381-1384;

Subject Index

  • Subject Index
    Subject Index Volume 2
    Mol Cancer Ther December 1 2003 2 (12) 1385-1401;

Back to top
PreviousNext
Molecular Cancer Therapeutics: 2 (12)
December 2003
Volume 2, Issue 12
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model

Jump to

  • Article
  • Acknowledgment to Reviewers
  • Author Index
  • Subject Index
Advertisement
  • Most Cited
  • Most Read
Loading
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • Truncated BRCA2 Contributes to PARPi Resistance
  • ERPAS to Predict Response to Endocrine Therapy
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Sialoglycan mAb for Cancer Immunotherapy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement